You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for HUMANA INC. v. INDIVIOR INC. (E.D. Pa. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in HUMANA INC. v. INDIVIOR INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for HUMANA INC. v. INDIVIOR INC. (E.D. Pa. 2020)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2020-09-18 1 Complaint (Attorney) Patent Title Number (1) 8,475,832 Sublingual and buccal…Title Number (I) 8,475,832 Sublingual and buccal film compositions …MonoSol patent asserted there, MonoSol and Indivior obtained new patents, and asserted a new patent (in …e. Patents: Patent Patent Title …Page 11 of 211 prosecuted patents on Suboxone in the United States Patent Office; it secured at least External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.